ChartTrends^®: Bone and Mineral Metabolism in CKD-ND (US)

An annual report providing patient level chart audit data to give insights into the management of bone and mineral metabolism in chronic kidney disease non-dialysis (CKD-ND) patients

Study Overview:

ChartTrends are syndicated reports designed to compare what physicians self-report about disease management to what actually occurs at the patient level. Through an in-depth review of specific patient charts, details such as product dosing and titration, switching, concomitant medications, and a host of laboratory and patient demographic variables help define patient types and identify therapy triggers.  The report will capture patient level data from 1000 unique later stage (Stage 3/4/5 not on dialysis) CKD patient records.  The data will be used to quantify the CKD-ND population and understand the treatment prevalence of and prescribing drivers for phosphate binders, Vitamin D, and Sensipar in this patient population.  This will be the 5thwave of the ChartTrends: Bone and Mineral Metabolism in CKD-ND (US) report.

Methodology:

Each nephrologist will complete a brief demographic, self-reported treatment prevalence, and attitudinal position profile upon registering to participate in the research.  Nephrologists will then complete 3-6 audits, for a total of 1000 audits, from later stage (Stage 3/4/5) CKD patient charts.  All methods are HIPAA compliant.

Sample Frame:

The report will include responses from a random sample of 200-250 nephrologists, providing information on 1,000 unique CKD-ND patients.  Patient charts must be from patients who are at least 18 years of age and have Stage 3, 4, or 5 CKD-ND.

Timing:

This report is fielded and published annually.  The final report will be delivered in September 30th.

Deliverables:

In addition to the final report, a complete set of frequency tables, summary statistics, and cross-tabulations will be provided.  Clients will also receive the patient database in SPSS.  Onsite or web-cast presentations are available upon request at no charge.